Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Other financing activities: 2022-2024

  • Phibro Animal Health's Other financing activities was N/A to $10.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $11.8 million, marking a year-over-year change of. This contributed to the annual value of $10.4 million for FY2025, which is N/A change from last year.
  • As of Q3 2024, Phibro Animal Health's Other financing activities stood at $10.4 million, which was up 1,145.74% from $833,000 recorded in Q2 2023.
  • Over the past 5 years, Phibro Animal Health's Other financing activities peaked at $10.4 million during Q3 2024, and registered a low of $71,000 during Q3 2022.
  • In the last 3 years, Phibro Animal Health's Other financing activities had a median value of $701,000 in 2022 and averaged $3.0 million.